Interaction of Choline and Fat in the Prenatal Programming of Nonalcoholic Steatohepatitis
胆碱和脂肪在非酒精性脂肪性肝炎产前规划中的相互作用
基本信息
- 批准号:10627414
- 负责人:
- 金额:$ 15.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-19 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAntioxidantsBetaineBlood GlucoseCharacteristicsCholineCholine DeficiencyCustomDNA MethylationDataDevelopmentDietDietary FatsDissociationEnvironmentEpigenetic ProcessExposure toFatty acid glycerol estersFetal LiverFetusFibrosisFish OilsFoodFructoseFundingGenesGlucose IntoleranceGrantHealthHepaticHigh Fat DietInflammationInsulin ResistanceIntakeInterventionJointsLactationLecithinLifeLipidsLipoproteinsLiverLong-Term EffectsMetabolicModernizationModificationMusNutrientObese MiceObesityOxidative StressPhospholipidsPlasmalogensPlayPolyunsaturated Fatty AcidsPopulationPredispositionPregnancyPrevalencePreventionProcessProphylactic treatmentPublic HealthResearchRisk FactorsRoleSupplementationTriglyceridesUnited States National Institutes of HealthWeaningblood glucose regulationcholine supplementationcognitive functioncompare effectivenesscost effectiveemerging adultepigenetic regulationfatty acid supplementationfeedinghepatocyte injuryhigh riskimprovedlardlipid biosynthesislipid metabolismlipidomicsmaternal obesitymethyl groupneurogenesisnonalcoholic steatohepatitisobesogenicoffspringpostnatalpostnatal periodprenatalpreventpromoterprophylacticprotective effectrisk mitigationsimple steatosisstable isotopesugarsynergismtheorieswestern diet
项目摘要
Summary
Nonalcoholic steatohepatitis (NASH), characterized by hepatic triglyceride accumulation and inflammation,
is a growing public health problem that affects about 7% of the U.S. population. It is hypothesized that maternal
obesity exerts the first metabolic hit to the fetal liver, priming it for fat accumulation and increased susceptibility
to NASH, whereas a postnatal obesogenic environment imposes further hits that result in NASH. In this proposal,
we will use choline, a semi-essential nutrient, to prevent the prenatal programming of NASH. Choline
plays an important role in lipid metabolism, facilitating hepatic lipid export and serving as a methyl donor which
modifies expression of lipid metabolic genes via an epigenetic mechanism. Prior research of our lab suggests
that maternal choline supplementation (MCS) in obese mouse dams prevented excess triglyceride accumulation
in the fetal liver partly by increasing the DNA methylation of the lipogenic gene Srebf1 and improved blood
glucose homeostasis in early adulthood. MCS also increased the abundance of long-chain polyunsaturated fatty
acids (LC-PUFAs) containing plasmalogens, a group of phospholipids that serve as sacrificial antioxidants, in
the offspring. Since the NASH liver is characterized by oxidative stress and LC-PUFA deficiency, MCS may
mitigate these risk factors of NASH. Interestingly, the beneficial effects of MCS was more prominent in offspring
whose dams also received high-fat (HF) feeding during gestation, suggesting an interaction between choline and
HF feeding. The objective of this study is to determine the interactive effect of CS with dietary fat on preventing
the prenatal programming of NASH. The overarching hypothesis is that prenatal and postnatal CS would
ameliorate NASH development initiated by a maternal HF, obesogenic diet; CS would synergize with LC-PUFA
supplementation to further prevent the prenatal programming of NASH. In Aim 1, we will determine the effect
of lifelong choline supplementation (CS) on preventing the prenatal programming of NASH by HF feeding.
Offspring mice born to HF-induced obese dams will receive a HF, high-fructose Western style diet (WD) post-
weaning to trigger NASH. Choline will be supplemented at different life stages to discern its effect by timing of
intervention during the prenatal period (first hit), postnatal period (later hits), or both (first and later hits). We
will use stable isotope tracing to discern the preferential partitioning of choline into its metabolic fates as
phosphatidylcholine or betaine, thereby influencing the hepatic lipidomic profile and epigenetic regulation later
in life. In Aim 2, we will determine the effect of CS and LC-PUFA co-supplementation on NASH prevention.
Both mouse dams and offspring will receive a fish oil supplemented HF or WD diet as well as CS. We will
compare the joint effect of fish oil and CS on NASH characteristics and lipidomic profile. This study will provide
proof-of-concept evidence for the use of choline alone or in combination with LC-PUFA as a cost-effective and
innocuous prophylactic agent for NASH programmed by prenatal and postnatal HF, obesogenic diet exposures.
总结
非酒精性脂肪性肝炎(NASH),以肝脏甘油三酯蓄积和炎症为特征,
这是一个日益严重的公共卫生问题,影响了大约7%的美国人口。据推测,
肥胖首先对胎儿肝脏造成代谢打击,使其开始脂肪积累并增加易感性
然而,出生后的致肥环境施加了导致NASH的进一步打击。在这一提议中,
我们将使用胆碱,一种半必需营养素,来预防NASH的产前编程。胆碱
在脂质代谢中起重要作用,促进肝脏脂质输出,并作为甲基供体,
通过表观遗传机制改变脂质代谢基因的表达。我们实验室之前的研究表明
在肥胖小鼠母鼠中母体胆碱补充剂(MCS)可防止过量甘油三酯蓄积,
在胎儿肝脏中,部分是通过增加脂肪生成基因Srebf 1的DNA甲基化,
葡萄糖稳态。MCS还增加了长链多不饱和脂肪酸的丰度,
含有缩醛磷脂(一组充当牺牲抗氧化剂的磷脂)的LC-PUFA,
后代。由于NASH肝脏的特征在于氧化应激和LC-PUFA缺乏,因此MCS可能
降低NASH的这些风险因素。有趣的是,MCS的有益效果在后代中更为突出,
其母鼠在妊娠期间也接受高脂(HF)喂养,表明胆碱和
高频喂养。本研究的目的是确定CS与膳食脂肪的交互作用,
NASH的产前编程。总体假设是产前和产后CS
改善由母体HF、致肥胖饮食引发的NASH发展; CS将与LC-PUFA协同作用
补充以进一步防止NASH的产前编程。在目标1中,我们将确定
终身胆碱补充(CS)对预防HF喂养引起的NASH产前编程的影响。
HF诱导的肥胖母鼠所生的后代小鼠将接受HF,高果糖西式饮食(WD),
断奶引发NASH胆碱将在不同的生命阶段补充,以通过时间来辨别其效果
在产前阶段(首次命中)、产后阶段(随后命中)或两者(首次和随后命中)进行干预。我们
将使用稳定同位素示踪来辨别胆碱优先分配到其代谢命运,
磷脂酰胆碱或甜菜碱,从而影响肝脏脂质组学特征和后期的表观遗传调节
生活中在目标2中,我们将确定CS和LC-PUFA共补充对NASH预防的作用。
小鼠母鼠和后代都将接受鱼油补充的HF或WD饮食以及CS。我们将
比较鱼油和CS对NASH特征和脂质组学特征的联合作用。本研究将提供
单独使用胆碱或与LC-PUFA组合使用胆碱作为具有成本效益和
用于通过产前和产后HF、致肥胖饮食暴露编程的NASH的无害预防剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xinyin Jiang其他文献
Xinyin Jiang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xinyin Jiang', 18)}}的其他基金
The lasting effect of maternal choline supplementation on lipid metabolism in mouse progeny affected by maternal obesity and gestational diabetes mellitus
母体补充胆碱对受母体肥胖和妊娠糖尿病影响的小鼠后代脂质代谢的持久影响
- 批准号:
10359140 - 财政年份:2019
- 资助金额:
$ 15.7万 - 项目类别:
The lasting effect of maternal choline supplementation on lipid metabolism in mouse progeny affected by maternal obesity and gestational diabetes mellitus
母体补充胆碱对受母体肥胖和妊娠糖尿病影响的小鼠后代脂质代谢的持久影响
- 批准号:
9903390 - 财政年份:2019
- 资助金额:
$ 15.7万 - 项目类别:
Effects of choline on fetal growth and lipid accretion in gestational diabetes
胆碱对妊娠期糖尿病胎儿生长和脂质沉积的影响
- 批准号:
9272392 - 财政年份:2015
- 资助金额:
$ 15.7万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 15.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 15.7万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 15.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 15.7万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 15.7万 - 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 15.7万 - 项目类别:
Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 15.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 15.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 15.7万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 15.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)